Nat Habit posts Rs 106 Cr revenue in FY25; losses surge 61%

Nat Habit, which recently rebranded itself as Breathe Life, has continued its growth momentum in the fiscal year ending March 2025 with strong scale expansion but remained in the red due to elevated advertising and operational costs.

The company’s revenue from operations grew 47% to Rs 106 crore in FY25 from Rs 72 crore in FY24, according to its financial statements sourced from the Registrar of Companies (RoC). 

Nat Habit has rebranded itself as Breathe Life, marking a shift in its positioning from a focused Ayurvedic brand to a broader lifestyle proposition. The company sells Ayurvedic personal care products, including shampoo, face wash, and moisturiser. Revenue during the fiscal year came entirely from the sale of these products.

On the spending side, advertising expenses remained the biggest cost driver for the company, accounting for 42% of the total expense. This cost surged 61% to Rs 58 crore in FY25 from Rs 36 crore in FY24. Employee benefit expenses rose 71% to Rs 24 crore, while cost of materials grew 75% to Rs 21 crore in FY25. 

Other overheads, including legal, rent, and miscellaneous expenses pushed the total expenses to Rs 138 crore, up 52% from Rs 91 crore in FY24. For a more detailed expense breakdown, refer to TheKredible.

Despite strong revenue growth, higher spending led to deeper losses. The company’s net loss rose 61% to Rs 29 crore in FY25 from Rs 18 crore in FY24. Its ROCE and EBITDA margin stood at -52.41% and -26.79% respectively.

On a unit level, Nat Habit spent Rs 1.30 to earn every rupee of operating revenue in FY25 as compared to Rs 1.26 in FY24. The Delhi-based company held cash and bank balances of Rs 28 crore, while its current assets stood at Rs 54 crore in FY25.

According to TheKredible, Nat Habit has raised a total of approx $16 million of funding to date, having Peak XV Partners, Fireside Ventures, and Whiteboard Capital as its lead investors. The company’s co-founders Swagatika Das and Gaurav Agarwal together own 33.1% of the company.

The firm has certainly been visible and active with its advertising, and presence on platforms like CRED, always an interesting place to spot interesting brands. Crossing the Rs 100 crore mark is a key milestone, diluted by the high advertising costs. The portfolio is the kind that has to develop user loyalty after high acquisition costs, and it remains to be seen if FY26 delivers clear signs of that, even at the risk of moderate growth but lower losses. The dilution of the sharp ayurvedic focus  and the brand change indicate a team in a hurry, and this year will be  a good test of that move.